Caspase-8 expression is predictive of tumour response to death receptor 5 agonist antibody in Ewing's sarcoma

BACKGROUND: Despite good initial response to chemotherapy, 30% of Ewing's sarcoma (EWS) patients with localised tumours develop recurrent disease, associated with poor prognosis. The aim of this study was to address this challenge by conducting preclinical evaluation of a death receptor targete...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Zhigang, Goldstein, Seth D, Yu, Yunkai, Meltzer, Paul S, Loeb, David M, Cao, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578089/
https://www.ncbi.nlm.nih.gov/pubmed/26291055
http://dx.doi.org/10.1038/bjc.2015.298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578089/
https://www.ncbi.nlm.nih.gov/pubmed/26291055
http://dx.doi.org/10.1038/bjc.2015.298

Ejemplares similares